Post-irradiation viability and cytotoxicity of natural killer cells isolated from human peripheral blood using different methods

References

• Bonavida B, Wright SC. 1982. Soluble cytotoxic factors and the mechanism of NK cell mediated cytotoxicity. Adv Exp Med Biol 146:379–388.
   PubMed Web of Science ®Google Scholar
• Böyum A. 1968. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 21(Suppl. 97):77–89.
   PubMed Web of Science ®Google Scholar
• Brovall C, Schacter B. 1981. Radiation sensitivity of human natural killer cell activity: Control by X-linked genes. J Immunol 126:2236–2239.
   PubMed Web of Science ®Google Scholar
• Bryceson YT, March ME, Ljunggren H, Long EO. 2006. Activation, coactivation, and costimulation of resting human natural killer cells. Immunol Rev 214:73–91.
   PubMed Web of Science ®Google Scholar
• Caligiuri MA. 2008. Human natural killer cells. Blood 112:461–469.
   PubMed Web of Science ®Google Scholar
• Cooper MA. 2001. Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset. Blood 97:3146–3151.
   PubMed Web of Science ®Google Scholar
• Dean DM, Pross HF, Kennedy JC. 1978. Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells – III. Stimulatory and inhibitory effects of ionizing radiation. Int J Radiat Oncol Biol Phys 4:633–641.
   PubMed Web of Science ®Google Scholar
• Deniz G, Akdis M, Aktas E, Blaser K, Akdis CA. 2002. Human NK1 and NK2 subsets determined by purification of IFN-gamma-secreting and IFN-gamma-non-secreting NK cells. Eur J Immunol 32:879–884.
   PubMed Web of Science ®Google Scholar
• Franzese O, Tricarico M, Starace G, Pepponi R, Bonmassar L, Cottarelli A, Fuggetta MP. 2013. Interferon-Beta combined with interleukin-2 restores human natural cytotoxicity impaired in vitro by ionizing radiations. J Interferon Cytokine Res 33:308–318.
   PubMed Web of Science ®Google Scholar
• Freud AG, Caligiuri MA. 2006. Human natural killer cell development. Immunol Rev 214:56–72.
   PubMed Web of Science ®Google Scholar
• Grzywacz B, Kataria N, Verneris MR. 2007. CD56(dim)CD16(+) NK cells downregulate CD16 following target cell induced activation of matrix metalloproteinases. Leukemia 21:356–359; author reply 359.
   PubMed Web of Science ®Google Scholar
• Hietanen T, Kellokumpu-Lehtinen P, Pitkanen M. 1995. Action of recombinant interferons and interleukin 2 in modulating radiation effects on viability and cytotoxicity of large granular lymphocytes. Int J Radiat Biol 67:119–126.
   PubMed Web of Science ®Google Scholar
• Kai S, Goto S, Tahara K, Sasaki A, Tone S, Kitano S. 2004. Indoleamine 2,3-dioxygenase is necessary for cytolytic activity of natural killer cells. Scand J Immunol 59:177–182.
   PubMed Web of Science ®Google Scholar
• Kiessling R, Klein E, Wigzell H. 1975. ‘Natural’ killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur J Immunol 5:112–117.
   PubMed Web of Science ®Google Scholar
• Lanier LL, Le AM, Phillips JH, Warner NL, Babcock GF. 1983. Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens. J Immunol 131:1789–1796.
   PubMed Web of Science ®Google Scholar
• Lozzio CB, Lozzio BB. 1975. Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood 45:321–334.
   PubMed Web of Science ®Google Scholar
• Makinodan T, James SJ. 1990. T cell potentiation by low dose ionizing radiation: possible mechanisms. Health Phys 59:29–34.
   PubMed Web of Science ®Google Scholar
• Malygin AM, Somersalo K, Timonen T. 1994. Promotion of natural killer cell growth in vitro by bispecific (anti-CD3 × anti-CD16) antibodies. Immunology 81:92–95.
   PubMed Web of Science ®Google Scholar
• McDowell KA, Hank JA, DeSantes KB, Capitini CM, Otto MS, Paul M. 2015. NK cell-based immunotherapies in pediatric oncology. J Pediatr Hematol Oncol 37:79–93.
   PubMed Web of Science ®Google Scholar
• Nagler A, Lanier LL, Cwirla S, Phillips JH. 1989. Comparative studies of human FcRIII-positive and negative natural killer cells. J Immunol 143:3183–3191.
   PubMed Web of Science ®Google Scholar
• Pappenheimer AM. 1917. Experimental studies upon lymphocytes: I. The reactions of lymphocytes under various experimental conditions. J Exp Med 25:633–650.
   PubMedGoogle Scholar
• Patrikoski M, Sivula J, Huhtala H, Helminen M, Salo F, Mannerstrom B, Miettinen S. 2014. Different culture conditions modulate the immunological properties of adipose stem cells. Stem Cells Transl Med 3:1220–1230.
   PubMed Web of Science ®Google Scholar
• Rana R, Vitale M, Mazzotti G, Manzoli L, Papa S. 1990. Radiosensitivity of human natural killer cells: binding and cytotoxic activities of natural killer cell subsets. Radiat Res 124:96.
   PubMed Web of Science ®Google Scholar
• Rodel F, Frey B, Manda K, Hildebrandt G, Hehlgans S, Keilholz L, Seegenschmiedt MH, Gaipl US, Rodel C. 2012. Immunomodulatory properties and molecular effects in inflammatory diseases of low-dose x-irradiation. Front Oncol 2:120.
   PubMedGoogle Scholar
• Saksela E, Timonen T, Ranki A, Hayry P. 1979. Morphological and functional characterization of isolated effector cells responsible for human natural killer activity to fetal fibroblasts and to cultured cell line targets. Immunol Rev 44:71–123.
   PubMed Web of Science ®Google Scholar
• Santoli D, Trinchieri G, Zmijewski CM, Koprowski H. 1976. HLA-related control of spontaneous and antibody-dependent cell-mediated cytotoxic activity in humans. J Immunol 117:765–770.
   PubMed Web of Science ®Google Scholar
• Schacter B, Hansal S, Arno J, LeVine MJ. 1985. Polymorphic radiation sensitivity of human natural killer activity: possible role of DNA strand breakage. Hum Immunol 14:49–58.
   PubMed Web of Science ®Google Scholar
• Shahabi V, Postow MA, Tuck D, Wolchok JD. 2015. Immune-priming of the tumor microenvironment by radiotherapy: rationale for combination with immunotherapy to improve anticancer efficacy. Am J Clin Oncol 38:90–97.
   PubMed Web of Science ®Google Scholar
• Shi J, Tricot G, Szmania S, Rosen N, Garg TK, Malaviarachchi PA, Moreno A, Dupont B, Hsu KC, Baxter-Lowe LA, Cottler-Fox M, Shaughnessy JD Jr, Barlogie B, van Rhee F. 2008. Infusion of haplo-identical killer immunoglobulin-like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantation. Br J Haematol 143:641–653.
   PubMed Web of Science ®Google Scholar
• Soukup K, Wang X. 2015. Radiation meets immunotherapy – a perfect match in the era of combination therapy? Int J Radiat Biol 91:299–305.
   PubMed Web of Science ®Google Scholar
• Spits H, Di Santo JP. 2011. The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. Nat Immunol 12:21–27.
   PubMed Web of Science ®Google Scholar
• Takahashi E, Kuranaga N, Satoh K, Habu Y, Shinomiya N, Asano T, Seki S, Hayakawa M. 2007. Induction of CD16+ CD56bright NK cells with antitumour cytotoxicity not only from CD16- CD56bright NK cells but also from CD16- CD56dim NK cells. Scand J Immunol 65:126–138.
   PubMed Web of Science ®Google Scholar
• Tang FR, Loke WK. 2015. Molecular mechanisms of low dose ionizing radiation-induced hormesis, adaptive responses, radioresistance, bystander effects, and genomic instability. Int J Radiat Biol 91:13–27.
   PubMed Web of Science ®Google Scholar
• Terme M, Ullrich E, Delahaye NF, Chaput N, Zitvogel L. 2008. Natural killer cell-directed therapies: moving from unexpected results to successful strategies. Nat Immunol 9:486–494.
   PubMed Web of Science ®Google Scholar
• Timonen T, Saksela E. 1980. Isolation of human NK cells by density gradient centrifugation. J Immunol Methods 36:285–291.
   PubMed Web of Science ®Google Scholar
• Timonen T, Ortaldo JR, Herberman RB. 1981. Characteristics of human large granular lymphocytes and relationship to natural killer and K cells. J Exp Med 153:569–582.
   PubMed Web of Science ®Google Scholar
• Vacca P, Moretta L, Moretta A, Mingari MC. 2011. Origin, phenotype and function of human natural killer cells in pregnancy. Trends Immunol 32:517–523.
   PubMed Web of Science ®Google Scholar
• Vivier E, Ugolini S, Blaise D, Chabannon C, Brossay L. 2012. Targeting natural killer cells and natural killer T cells in cancer. Nat Rev Immunol 12:239–252.
   PubMed Web of Science ®Google Scholar
• Vokurková D, Vávrová J, Šinkora J, Stoklasová A, Bláha V, Rezácová M. 2010. Radiosensitivity of CD3-CD8 + CD56 + NK cells. Radiat Measur 45:1020–1023.
   Web of Science ®Google Scholar
• Walzer T, Jaeger S, Chaix J, Vivier E. 2007. Natural killer cells: from CD3(-)NKp46(+) to post-genomics meta-analyses. Curr Opin Immunol 19:365–372.
   PubMed Web of Science ®Google Scholar
• Zaretskaya YM, Burkhanov RA, Dolbin AG, Metodiev KT. 1983. Factors responsible for fluctuations in human NK cell activity in vitro. J Immunol Methods 64:321–326.
   PubMed Web of Science ®Google Scholar
• Zaritskaya L, Shurin MR, Sayers TJ, Malyguine AM. 2010. New flow cytometric assays for monitoring cell-mediated cytotoxicity. Expert Rev Vaccines 9:601–616.
   PubMed Web of Science ®Google Scholar